GENERICally Speaking Hatch Waxman Bulletin

The Hatch-Waxman Litigation practice group at Robins Kaplan LLP is pleased to offer the latest edition of their quarterly publication regarding ANDA patent litigation issues and the generics business.

GENERICally Speaking Fall 2020

Fall 2020

The Fall 2020 issue of GENERICally Speaking provides you and your company with some of the knowledge beneficial to remaining attentive to the complexity of ANDA patent litigation.

A few of the relevant court decisions highlighted in this issue:

Relevant ANDA Updates highlighted in this issue:

Reported settlements in federal district court cases
Federal district court cases that are filed pursuant to the Hatch-Waxman Act
Tecfidera®/dimethyl fumarate
Minivelle®/estradiol transdermal system
Riomet®/metformin HCl
Tirosint®/levothyroxine sodium

GENERICally Speaking Winter 2020

Winter 2020

GENERICally Speaking Spring 2020

Spring 2020

GENERICally Speaking Summer 2020

Summer 2020